García-Arriaza, J.; Falqui, M.; Pérez, P.; Coloma, R.; Perdiguero, B.; Álvarez, E.; Marcos-Villar, L.; Astorgano, D.; Campaña-Gómez, I.; Sorzano, C.Ó.S.;
et al. ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. Vaccines 2025, 13, 696.
https://doi.org/10.3390/vaccines13070696
AMA Style
García-Arriaza J, Falqui M, Pérez P, Coloma R, Perdiguero B, Álvarez E, Marcos-Villar L, Astorgano D, Campaña-Gómez I, Sorzano CÓS,
et al. ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. Vaccines. 2025; 13(7):696.
https://doi.org/10.3390/vaccines13070696
Chicago/Turabian Style
García-Arriaza, Juan, Michela Falqui, Patricia Pérez, Rocío Coloma, Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, David Astorgano, Irene Campaña-Gómez, Carlos Óscar S. Sorzano,
and et al. 2025. "ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2" Vaccines 13, no. 7: 696.
https://doi.org/10.3390/vaccines13070696
APA Style
García-Arriaza, J., Falqui, M., Pérez, P., Coloma, R., Perdiguero, B., Álvarez, E., Marcos-Villar, L., Astorgano, D., Campaña-Gómez, I., Sorzano, C. Ó. S., Esteban, M., Gómez, C. E., & Guerra, S.
(2025). ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2. Vaccines, 13(7), 696.
https://doi.org/10.3390/vaccines13070696
